混合部位脑出血与脑微出血患者皮质表面铁沉积的机制意义
基于前瞻性数据库连续入组非创伤性脑出血患者,比较混合部位脑出血伴皮质表面铁沉积(cSS)与不伴cSS者的脑淀粉样血管病(CAA)影像标志物和左心室肥厚频率。伴cSS组左心室肥厚更少(34% vs 59%),多灶性白质高信号模式和重度半卵圆中心 enlarged perivascular spaces(CSO-EPVS)更多,校正后年龄、无左心室肥厚、多灶性白质高信号模式和重度CSO-EPVS与cSS独立相关;伴cSS组脑出血复发风险更高(校正HR 4.65)。作者认为伴cSS的混合部位脑出血可能同时涉及高血压性小血管病和CAA。
要点
- 混合部位脑出血伴cSS者左心室肥厚比例低于不伴cSS者(34% vs 59%)。
- 多灶性白质高信号模式和重度CSO-EPVS在伴cSS组更常见,且与cSS独立相关。
- 伴cSS的混合部位脑出血患者脑出血复发风险较不伴cSS者升高(校正HR 4.65)。
核心结论
- 伴cSS的混合部位脑出血的潜在微血管病可能同时包括高血压性小血管病和CAA,而不伴cSS者可能主要由高血压性小血管病驱动。
- 基于影像的分类可能有助于分层脑出血风险,但需在纳入先进影像/病理的研究中确认。
研究设计与样本
- 对转诊中心前瞻性数据库连续入组的非创伤性脑出血患者脑MRI进行回顾,评估脑微出血、cSS及非出血性CAA标志物。
- 共纳入1791例脑出血患者,其中伴cSS的混合部位脑出血40例,不伴cSS的混合部位脑出血256例。
- 采用单变量和多变量模型比较两组CAA标志物及左心室肥厚频率。
主要发现
- 伴cSS的混合部位脑出血组左心室肥厚比例低于不伴cSS组(34% vs 59%,p=0.01)。
- 伴cSS组多灶性白质高信号模式频率高于不伴cSS组(18% vs 4%,p<0.01)。
- 伴cSS组重度CSO-EPVS频率高于不伴cSS组(33% vs 11%,p<0.01)。
- 校正高血压和冠心病后,年龄较大(每岁aOR 1.04,95%CI 1.00-1.07,p=0.04)、无左心室肥厚(aOR 0.41,95%CI 0.19-0.89,p=0.02)、多灶性白质高信号模式(aOR 5.25,95%CI 1.63-16.94,p=0.01)和重度CSO-EPVS(aOR 4.24,95%CI 1.78-10.13,p<0.01)与伴cSS的混合部位脑出血独立相关。
- 在脑出血存活者中,伴cSS的混合部位脑出血组脑出血复发的校正HR为4.65(95%CI 1.38-11.38,p<0.01),对照为不伴cSS的混合部位脑出血组。
关键数值与推荐
- 伴cSS的混合部位脑出血组左心室肥厚34% vs 不伴cSS组59%(p=0.01)。
- 伴cSS组多灶性白质高信号模式18% vs 不伴cSS组4%(p<0.01)。
- 伴cSS组重度CSO-EPVS 33% vs 不伴cSS组11%(p<0.01)。
- 年龄每增加1岁aOR 1.04(95%CI 1.00-1.07,p=0.04);无左心室肥厚aOR 0.41(95%CI 0.19-0.89,p=0.02);多灶性白质高信号模式aOR 5.25(95%CI 1.63-16.94,p=0.01);重度CSO-EPVS aOR 4.24(95%CI 1.78-10.13,p<0.01)。
- 脑出血复发校正HR 4.65(95%CI 1.38-11.38,p<0.01),伴cSS组对照不伴cSS组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Hypertensive cerebral small vessel disease (HTN-cSVD) is the predominant microangiopathy in patients with a combination of lobar and deep cerebral microbleeds (CMBs) and intracerebral hemorrhage (mixed ICH). We tested the hypothesis that cerebral amyloid angiopathy (CAA) is also a contributing microangiopathy in patients with mixed ICH with cortical superficial siderosis (cSS), a marker strongly associated with CAA. METHODS: Brain MRIs from a prospective database of consecutive patients with nontraumatic ICH admitted to a referral center were reviewed for the presence of CMBs, cSS, and nonhemorrhagic CAA markers (lobar lacunes, centrum semiovale enlarged perivascular spaces [CSO-EPVS], and multispot white matter hyperintensity [WMH] pattern). The frequencies of CAA markers and left ventricular hypertrophy (LVH), a marker for hypertensive end-organ damage, were compared between patients with mixed ICH with cSS (mixed ICH/cSS[+]) and without cSS (mixed ICH/cSS[-]) in univariate and multivariable models. RESULTS: Of 1,791 patients with ICH, 40 had mixed ICH/cSS(+) and 256 had mixed ICH/cSS(-). LVH was less common in patients with mixed ICH/cSS(+) compared with those with mixed ICH/cSS(-) (34% vs 59%, p = 0.01). The frequencies of CAA imaging markers, namely multispot pattern (18% vs 4%, p < 0.01) and severe CSO-EPVS (33% vs 11%, p < 0.01), were higher in patients with mixed ICH/cSS(+) compared with those with mixed ICH/cSS(-). In a logistic regression model, older age (adjusted odds ratio [aOR] 1.04 per year, 95% CI 1.00-1.07, p = 0.04), lack of LVH (aOR 0.41, 95% CI 0.19-0.89, p = 0.02), multispot WMH pattern (aOR 5.25, 95% CI 1.63-16.94, p = 0.01), and severe CSO-EPVS (aOR 4.24, 95% CI 1.78-10.13, p < 0.01) were independently associated with mixed ICH/cSS(+) after further adjustment for hypertension and coronary artery disease. Among ICH survivors, the adjusted hazard ratio of ICH recurrence in patients with mixed ICH/cSS(+) was 4.65 (95% CI 1.38-11.38, p < 0.01) compared with that in patients with mixed ICH/cSS(-). DISCUSSION: The underlying microangiopathy of mixed ICH/cSS(+) likely includes both HTN-cSVD and CAA, whereas mixed ICH/cSS(-) is likely driven by HTN-cSVD. These imaging-based classifications can be important to stratify ICH risk but warrant confirmation in studies incorporating advanced imaging/pathology.
引用
- Das AS, Gokcal E, Biffi A, et al. Mechanistic Implications of Cortical Superficial Siderosis in Patients With Mixed Location Intracerebral Hemorrhage and Cerebral Microbleeds. Neurology. 2023. PMID: 37290968. doi:10.1212/WNL.0000000000207476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。